{"id":"https://openalex.org/W2242675868","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.8070","title":"First-line gefitinib for poor PS patients with EGFR mutations","display_name":"First-line gefitinib for poor PS patients with EGFR mutations","publication_year":2008,"publication_date":"2008-05-20","ids":{"openalex":"https://openalex.org/W2242675868","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.8070","mag":"2242675868"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2008.26.15_suppl.8070","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.8070","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2008.26.15_suppl.8070","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101480010","display_name":"Kazuma Kobayashi","orcid":"https://orcid.org/0000-0002-4249-9933","observed_orcids":["https://orcid.org/0000-0002-4249-9933"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Kobayashi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065197178","display_name":"A. Inoue","orcid":"https://orcid.org/0000-0002-2954-2722","observed_orcids":["https://orcid.org/0000-0002-2954-2722"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Inoue","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085358387","display_name":"Kazuhiro Usui","orcid":"https://orcid.org/0000-0002-4492-9327","observed_orcids":["https://orcid.org/0000-0002-4492-9327"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Usui","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007143858","display_name":"Makoto Maemondo","orcid":"https://orcid.org/0000-0002-1950-1943","observed_orcids":["https://orcid.org/0000-0002-1950-1943"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Maemondo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043047683","display_name":"Shoji Okinaga","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Okinaga","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086157085","display_name":"Iwao Mikami","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I. Mikami","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"M. Ando","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Ando","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011533142","display_name":"Akihiko Gemma","orcid":"https://orcid.org/0000-0003-0762-2737","observed_orcids":["https://orcid.org/0000-0003-0762-2737"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Gemma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112712356","display_name":"Shoko H. Morita","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Morita","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110576041","display_name":"Kanako Ito Hagiwara","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Hagiwara","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":"15_suppl","first_page":"8070","last_page":"8070"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.996999979019165},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.9129999876022339},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8920000195503235},{"id":"https://openalex.org/keywords/poor-performance-status","display_name":"poor performance status","score":0.9610000252723694},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.8669999837875366},{"id":"https://openalex.org/keywords/egfr-exon-19-deletion","display_name":"EGFR exon 19 deletion","score":0.7990000247955322},{"id":"https://openalex.org/keywords/egfr-l858r-mutation","display_name":"L858R mutation","score":0.9039999842643738},{"id":"https://openalex.org/keywords/l861q-mutation","display_name":"L861Q mutation","score":0.8899999856948853},{"id":"https://openalex.org/keywords/adenocarcinoma","display_name":"adenocarcinoma","score":0.8930000066757202},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7089999914169312},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7699999809265137},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.5180000066757202},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.6079999804496765}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8509018421173096},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.7834187746047974},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.633936882019043},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6099038124084473},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.5558948516845703},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.49455854296684265},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.44796115159988403},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4349663257598877},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.4280267655849457},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.4212121069431305},{"id":"https://openalex.org/C2779634585","wikidata":"https://www.wikidata.org/wiki/Q1334541","display_name":"Pleural effusion","level":2,"score":0.4194844365119934},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3948301672935486},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3900598883628845},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.3563799560070038},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.2050994634628296},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.14506545662879944}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2008.26.15_suppl.8070","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.8070","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2008.26.15_suppl.8070","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2111191667","https://openalex.org/W2562594020","https://openalex.org/W2224073610","https://openalex.org/W2249538727","https://openalex.org/W2069312070","https://openalex.org/W2298507739","https://openalex.org/W2093922887","https://openalex.org/W2243266097","https://openalex.org/W2152894558","https://openalex.org/W2230979823"],"abstract_inverted_index":{"8070":[0],"Background:":[1],"We":[2],"had":[3],"previously":[4],"reported":[5],"several":[6],"phase":[7,40],"II":[8,41],"studies":[9],"using":[10,79],"good":[11],"performance":[12,249],"status":[13],"(PS)":[14],"patients":[15,169,247,255,309,330,354],"(pts)":[16],"with":[17,57,95,180,256,303,316,331],"advanced":[18,92,307],"non-small":[19],"cell":[20],"lung":[21],"cancer":[22],"(NSCLC)":[23],"harboring":[24,310],"epidermal":[25],"growth":[26],"factor":[27],"receptor":[28],"(EGFR)":[29],"mutations":[30,78,100,343],"(JCO,":[31],"2006:24,":[32],"3340,":[33],"BJC,":[34],"2006:95,":[35],"998,":[36],"and":[37,49,85,98,109,125,157,165,175,195,217,231,272,281],"1483).":[38],"This":[39,290],"study":[42,294],"was":[43,133,224,236,287],"undertaken":[44],"to":[45,135,140,229,243,262,368],"investigate":[46],"the":[47,103,142,173,188,232,246,254,292],"efficacy":[48,302],"feasibility":[50],"of":[51,145,152,154,245,253,341],"gefitinib":[52,111,181,298],"for":[53,183,328],"poor":[54,96,318],"PS":[55,97,122,158,193,257,263],"pts":[56,94,139,177,216],"EGFR":[58,77,99,311,342,360],"mutations.":[59],"Methods:":[60],"The":[61,115,220,265],"peptide":[62],"nucleic":[63,65],"acid-locked":[64],"acid":[66],"polymerase":[67],"chain":[68],"reaction":[69],"clamp":[70,106],"method":[71],"(PNA-LNA":[72],"PCR":[73,105],"clamp)":[74],"can":[75],"detect":[76],"cytology":[80],"specimens":[81],"such":[82],"as":[83],"sputum":[84],"pleural":[86],"effusion":[87],"(Cancer":[88],"Res,":[89],"2005;65:7276).":[90],"Chemona\u00efve":[91],"NSCLC":[93,308],"examined":[101],"by":[102,359],"PNA-LNA":[104],"were":[107,128,170,178,276],"enrolled":[108,171],"received":[110],"(250":[112],"mg/day)":[113],"alone.":[114],"response":[116,155,222],"rate,":[117],"progression-free":[118,267],"survival,":[119,121,268],"overall":[120,221],"improvement":[123,159],"rate":[124,156,223,235,275],"toxicity":[126,305],"profile":[127],"assessed":[129],"prospectively.":[130],"Sample":[131],"size":[132],"decided":[134],"be":[136,357],">":[137,150],"25":[138],"show":[141],"lower":[143],"limit":[144],"90%":[146],"confidence":[147],"interval":[148],"(CI)":[149],"50%":[151],"each":[153],"rate.":[160],"Results:":[161],"Between":[162],"February":[163],"2006":[164],"May":[166],"2007,":[167],"30":[168],"into":[172],"study,":[174],"29":[176],"treated":[179],"except":[182],"an":[184],"early":[185],"death":[186,286],"before":[187],"treatment":[189,299,327],"(PS":[190],"3\u20134:22":[191],"pts,":[192,214],"1\u20132":[194],"over":[196],"80":[197],"years":[198],"old:7":[199],"pts;":[200,207,210],"7":[201],"males/22":[202],"females;":[203],"median":[204,266,269],"age:72;":[205],"adenocarcinoma:27":[206],"Stage":[208],"IV:27":[209],"exon":[211],"19":[212],"del:18":[213],"L858R:10":[215],"L861Q:1":[218],"pt).":[219],"66%":[225],"(90%":[226,240],"CI,":[227,241],"51":[228],"80)":[230],"disease":[233],"control":[234],"90%.":[237],"And":[238],"79%":[239],"63":[242],"91)":[244],"improved":[248,261],"status.":[250],"Especially,":[251],"65%":[252],"3\u20134":[258],"at":[259],"baseline":[260],"0\u20131.":[264],"survival":[270,274],"time,":[271],"1-year":[273],"9.3":[277],"months,":[278],"17.8":[279],"months":[280],"73%,":[282],"respectively.":[283],"No":[284,364],"treatment-related":[285],"observed.":[288],"Conclusions:":[289],"is":[291,344],"first":[293],"suggesting":[295],"that":[296],"first-line":[297],"provides":[300],"high":[301],"acceptable":[304],"in":[306,314,347],"mutations,":[312],"even":[313],"those":[315],"extremely":[317],"PS.":[319],"Since":[320],"there":[321],"has":[322],"hitherto":[323],"been":[324],"no":[325],"standard":[326],"these":[329],"short":[332],"life":[333],"expectancy":[334],"other":[335],"than":[336],"best":[337],"supportive":[338],"care,":[339],"examination":[340],"strongly":[345],"recommended":[346],"this":[348],"patient":[349],"population":[350],"because":[351],"it":[352],"identifies":[353],"who":[355],"may":[356],"salvaged":[358],"tyrosine":[361],"kinase":[362],"inhibitors.":[363],"significant":[365],"financial":[366],"relationships":[367],"disclose.":[369]},"counts_by_year":[{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}